A citation-based method for searching scientific literature

Rui Liu, Jing Liu, Shuqing Wang, Yinsong Wang, Tao Zhang, Yang Liu, Xin Geng, Feng Wang. Cell Death Dis 2019
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Emodin Inhibits the Proliferation of MCF-7 Human Breast Cancer Cells Through Activation of Aryl Hydrocarbon Receptor (AhR).
Ning Zhang, Jiawen Wang, Aimin Sheng, Shuo Huang, Yanyan Tang, Shitang Ma, Ge Hong. Front Pharmacol 2021
1
100

Emodin sensitizes paclitaxel-resistant human ovarian cancer cells to paclitaxel-induced apoptosis in vitro.
Juan Li, Peishu Liu, Hongluan Mao, Ancong Wanga, Xiaolei Zhang. Oncol Rep 2009
51
100

Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe.
Wojciech Trybus, Teodora Król, Ewa Trybus, Anna Stachurska, Grzegorz Król, Anna Kopacz-Bednarska. Anticancer Res 2019
5
100

Antitumor activity of emodin against pancreatic cancer depends on its dual role: promotion of apoptosis and suppression of angiogenesis.
Sheng-Zhang Lin, Wei-Tian Wei, Hui Chen, Kang-Jie Chen, Hong-Fei Tong, Zhao-Hong Wang, Zhong-Lin Ni, Hai-Bin Liu, Hong-Chun Guo, Dian-Lei Liu. PLoS One 2012
51
100

Inhibition of human tumor cell proliferation by novel anthraquinones from daylilies.
Robert H Cichewicz, Yanjun Zhang, Navindra P Seeram, Muraleedharan G Nair. Life Sci 2004
39
100

Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production.
Yen-Chou Chen, Shing-Chuan Shen, Woan-Ruoh Lee, Foun-Lin Hsu, Hui-Yi Lin, Ching-Huai Ko, Shi-Wen Tseng. Biochem Pharmacol 2002
170
100

The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
Hui Xue, Yang Chen, Xiaopeng Cai, Lei Zhao, Anning He, Kejun Guo, Xinyu Zheng. Anticancer Drugs 2013
10
100

Emodin induces embryonic toxicity in mouse blastocysts through apoptosis.
Mei-Hui Chang, Fu-Jen Huang, Wen-Hsiung Chan. Toxicology 2012
27
100

Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer.
Min Fu, Wei Tang, Jing-Jing Liu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li, Rui-Jun Ju. J Drug Target 2020
9
100

Emodin induces hepatocellular carcinoma cell apoptosis through MAPK and PI3K/AKT signaling pathways in vitro and in vivo.
Wanfu Lin, Maofeng Zhong, Huixia Yin, Yongan Chen, Qingxin Cao, Chen Wang, Changquan Ling. Oncol Rep 2016
25
100

Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.
Steffi K Koerner, Jun-Ichi Hanai, Sha Bai, Finith E Jernigan, Miwa Oki, Chieko Komaba, Emi Shuto, Vikas P Sukhatme, Lijun Sun. Eur J Med Chem 2017
23
100


Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells.
Ling Zhang, Dian He, Kun Li, Hongli Liu, Baitao Wang, Lifang Zheng, Jiazhong Li. Biomed Pharmacother 2017
11
100

Emodin Induces Apoptosis of Colon Cancer Cells via Induction of Autophagy in a ROS-Dependent Manner.
Yuanyuan Wang, Qin Luo, Xianlu He, He Wei, Ting Wang, Jichun Shao, Xinni Jiang. Oncol Res 2018
19
100

Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.
L Zhang, Y K Lau, L Xi, R L Hong, D S Kim, C F Chen, G N Hortobagyi, C Chang, M C Hung. Oncogene 1998
91
100

Generation of oxygen free radicals in thyroid cells and inhibition of thyroid peroxidase.
Masahiro Sugawara, Yoshinobu Sugawara, Katherine Wen, Cecilia Giulivi. Exp Biol Med (Maywood) 2002
33
100

Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.
Young-Seon Kim, Yoon-Mi Lee, Taek-In Oh, Dong Hoon Shin, Geon-Hee Kim, Sang-Yeon Kan, Hyeji Kang, Ji Hyung Kim, Byeong Mo Kim, Woo Jong Yim,[...]. Int J Mol Sci 2018
25
100

Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis.
Wing-Yan Li, Yam-Fung Ng, Huan Zhang, Zi-Dong Guo, De-Jian Guo, Yiu-Wa Kwan, George Pak-Heng Leung, Simon Ming-Yuen Lee, Peter Hoi-Fu Yu, Shun-Wan Chan. Inflammopharmacology 2014
17
100

Inhibitory effect of emodin on fatty acid synthase, colon cancer proliferation and apoptosis.
Kyung Ha Lee, Myung Sun Lee, Eun Young Cha, Ji Young Sul, Jin Sun Lee, Jin Su Kim, Jun Beom Park, Ji Yeon Kim. Mol Med Rep 2017
17
100

Emodin and Aloe-Emodin Suppress Breast Cancer Cell Proliferation through ER α Inhibition.
Pao-Hsuan Huang, Chih-Yang Huang, Mei-Chih Chen, Yueh-Tsung Lee, Chia-Herng Yue, Hsin-Yi Wang, Ho Lin. Evid Based Complement Alternat Med 2013
54
100

Emodin inhibits tumor cell adhesion through disruption of the membrane lipid Raft-associated integrin signaling pathway.
Qing Huang, Han-Ming Shen, Guanghou Shui, Markus R Wenk, Choon-Nam Ong. Cancer Res 2006
90
100

Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro.
Jie-yu Xing, Gao-peng Song, Jun-peng Deng, Ling-zhi Jiang, Ping Xiong, Bin-jie Yang, Shan-shan Liu. PLoS One 2015
15
100

Induction of apoptosis in hepatocellular carcinoma cell lines by emodin.
Xubin Jing, Noboru Ueki, Jidong Cheng, Hiroyasu Imanishi, Toshikazu Hada. Jpn J Cancer Res 2002
73
100

Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors.
Bilel Jelassi, Monique Anchelin, Julie Chamouton, María Luisa Cayuela, Lucie Clarysse, Junying Li, Jacques Goré, Lin-Hua Jiang, Sébastien Roger. Carcinogenesis 2013
79
100

Anti-tumor effect of emodin on gynecological cancer cells.
Yaoxian Wang, Hui Yu, Jin Zhang, Xin Ge, Jing Gao, Yunyan Zhang, Ge Lou. Cell Oncol (Dordr) 2015
20
100

Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides.
Xuemei Jia, Stephen Iwanowycz, Junfeng Wang, Fatma Saaoud, Fang Yu, Yuzhen Wang, Jun Hu, Saurabh Chatterjee, Qian Wang, Daping Fan. Exp Biol Med (Maywood) 2014
26
100

Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
Akihiro Muto, Mayumi Hori, Yosuke Sasaki, Akari Saitoh, Iho Yasuda, Tadahito Maekawa, Tomoe Uchida, Keiko Asakura, Tomonori Nakazato, Toshio Kaneda,[...]. Mol Cancer Ther 2007
82
100

Inhibition of tamoxifen's therapeutic effects by emodin in estrogen receptor-positive breast cancer cell lines.
Yun Gyoung Kim, Yoon Hwa Park, Eun Yoel Yang, Won Seo Park, Kyoung Sik Park. Ann Surg Treat Res 2019
3
100

Silk fibroin mediated delivery of liposomal emodin to breast cancer cells.
Sangeeta K Cheema, Andrea S Gobin, Robyn Rhea, Gabriel Lopez-Berestein, Robert A Newman, Anshu B Mathur. Int J Pharm 2007
35
100

Emodin suppresses growth and invasion of colorectal cancer cells by inhibiting VEGFR2.
Guoliang Dai, Kang Ding, Qianyu Cao, Tian Xu, Fan He, Shijia Liu, Wenzheng Ju. Eur J Pharmacol 2019
11
100

Effects of Aloe-emodin and Emodin on Proliferation of the MKN45 Human Gastric Cancer Cell Line.
Takeshi Chihara, Kan Shimpo, Hidehiko Beppu, Naoki Yamamoto, Takaaki Kaneko, Kazumasa Wakamatsu, Shigeru Sonoda. Asian Pac J Cancer Prev 2015
17
100

Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
Jen-Chung Ko, Ying-Jhen Su, Szu-Ting Lin, Jhih-Yuan Jhan, Shih-Ci Ciou, Chao-Min Cheng, Yu-Fan Chiu, Ya-Hsun Kuo, Min-Shao Tsai, Yun-Wei Lin. Lung Cancer 2010
34
100

Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Xiaoyun Song, Xiqiu Zhou, Yuenong Qin, Jianfeng Yang, Yu Wang, Zhenping Sun, Kui Yu, Shuai Zhang, Sheng Liu. Int J Mol Med 2018
7
100

Synthesis and active oxygen generation by new emodin derivatives and their gonadotropin-releasing hormone conjugates.
Vered Lev-Goldman, Brenda Mester, Nurit Ben-Aroya, Yitzhak Koch, Lev Weiner, Mati Fridkin. Bioconjug Chem 2006
7
100


Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu.
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, Li-kun Chen, Satyakam Singh, Fang Wang, Jian-ye Zhang, Yong-ju Liang, Chun-ling Dai, Lian-quan Gu,[...]. Mol Pharm 2011
34
100


Emodin negatively affects the phosphoinositide 3-kinase/AKT signalling pathway: a study on its mechanism of action.
Birgitte B Olsen, Marina Bjørling-Poulsen, Barbara Guerra. Int J Biochem Cell Biol 2007
41
100


Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
Francis Giraud, Rufine Akué-Gédu, Lionel Nauton, Nicolas Candelon, Eric Debiton, Vincent Théry, Fabrice Anizon, Pascale Moreau. Eur J Med Chem 2012
14
100

Anti-cancer properties of anthraquinones from rhubarb.
Qing Huang, Guodong Lu, Han-Ming Shen, Maxey C M Chung, Choon Nam Ong. Med Res Rev 2007
297
100


Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Shengpeng Wang, Tongkai Chen, Ruie Chen, Yangyang Hu, Meiwan Chen, Yitao Wang. Int J Pharm 2012
73
100

Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.
Shih-Chang Chien, Yueh-Chen Wu, Zeng-Weng Chen, Wen-Chin Yang. Evid Based Complement Alternat Med 2015
31
100


Emodin induces apoptosis of human cervical cancer cells through poly(ADP-ribose) polymerase cleavage and activation of caspase-9.
Gopal Srinivas, Ruby John Anto, Priya Srinivas, Subramanian Vidhyalakshmi, Vijayamma Priya Senan, Devarajan Karunagaran. Eur J Pharmacol 2003
132
100

Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway.
Jin Su, Yan Yan, Jingkun Qu, Xuewen Xue, Zi Liu, Hui Cai. Oncol Rep 2017
23
100

Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
Jen-Chung Ko, Min-Shao Tsai, Ya-Hsun Kuo, Yu-Fan Chiu, Shao-Hsing Weng, Ying-Chen Su, Yun-Wei Lin. Biochem Pharmacol 2011
19
100




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.